The 21st Century Cures bill passed on a 344-77 vote, attracting significant bipartisan support in the House. It includes multiple provisions supported by the device industry, including a priority review pathway for breakthrough devices. Attention now moves to the Senate, which is working on its own bill that could face budget barriers and calls for more safety protections.
A string of FDA and other reforms intended to accelerate the path to market for device and drugs was passed by the House July 10 in the form of the 21st Century Cures Act.
The Cures bill (H.R. 6) passed on a 344-77 vote, attracting significant bipartisan support. It includes multiple provisions supported by...